Hong Kong-based multinational conglomerate Jardine Matheson has announced a definitive agreement to purchase a 100% equity stake in I-MED Radiology Network (I-MED), Australia’s premier medical imaging service provider. The transactional architecture values the targeted healthcare network at an enterprise valuation of A$3.4 billion (approximately $2.43 billion). The total share volume will be acquired from institutional funds managed by the private equity firm Permira alongside alternative minority shareholders.
The primary commercial elements and logistical metrics governing the transaction feature:
-
Operational Footprint: According to verified corporate data, I-MED anchors an expansive clinical infrastructure consisting of over 230 diagnostic imaging centers distributed throughout regional and metropolitan sectors across Australia and New Zealand. The network previously deferred a planned A$500 million initial public offering (IPO) in 2015 due to widespread macroeconomic volatility across global capital markets.
-
Integrated Artificial Intelligence Assets: The buyout package package encompasses I-MED’s existing proprietary minority stake in Harrison.ai, an innovative Australia-based biological software developer specializing in radiology-focused AI solutions, notably automated chest and brain CT scan matrixes.
-
Financial Sourcing: The 190-year-old conglomerate, which maintains heavily diversified asset portfolios spanning real estate, retail operations, and automotive logistics, noted that the acquisition capital will be deployed entirely via current corporate cash reserves combined with structured debt financing. The transaction is projected to be immediately earnings-accretive upon close.
The corporate buyout enables Jardine Matheson to rapidly establish a high-density footprint within the robust Asia-Pacific healthcare infrastructure market, diversifying its traditional revenue generation channels beyond its historical industrial baselines.